BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33458656)

  • 1. Prevalence of Subclinical Carotid Atherosclerosis and Vitamin D Deficiency in Egyptian Ankylosing Spondylitis Patients.
    Fotoh DS; Serag DM; Badr IT; Saif DS
    Arch Rheumatol; 2020 Sep; 35(3):335-342. PubMed ID: 33458656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid intima-media thickness and paraoxonase activity in patients with ankylosing spondylitis.
    Cece H; Yazgan P; Karakas E; Karakas O; Demirkol A; Toru I; Aksoy N
    Clin Invest Med; 2011 Aug; 34(4):E225. PubMed ID: 21810380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis.
    Gupta N; Saigal R; Goyal L; Agrawal A; Bhargava R; Agrawal A
    Int J Rheumatol; 2014; 2014():839135. PubMed ID: 24803936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epicardial adipose tissue thickness as a new risk factor for atherosclerosis in patients with ankylosing spondylitis.
    Surucu GD; Yildirim A; Yetisgin A; Akturk E
    J Back Musculoskelet Rehabil; 2019; 32(2):237-243. PubMed ID: 30248026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atherogenic index of plasma: a useful marker for subclinical atherosclerosis in ankylosing spondylitis : AIP associate with cIMT in AS.
    Cure E; Icli A; Uslu AU; Sakiz D; Cure MC; Baykara RA; Yavuz F; Arslan S; Kucuk A
    Clin Rheumatol; 2018 May; 37(5):1273-1280. PubMed ID: 29435680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired endothelial function in patients with ankylosing spondylitis.
    Sari I; Okan T; Akar S; Cece H; Altay C; Secil M; Birlik M; Onen F; Akkoc N
    Rheumatology (Oxford); 2006 Mar; 45(3):283-6. PubMed ID: 16204374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Atherosclerosis in Ankylosing Spondylitis.
    Verma I; Krishan P; Syngle A
    Rheumatol Ther; 2015 Dec; 2(2):173-182. PubMed ID: 27747533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of serum osteoprotegerin with arterial stiffness, preclinical atherosclerosis, and disease activity in patients with ankylosing spondylitis.
    Serdaroğlu Beyazal M; Erdoğan T; Türkyılmaz AK; Devrimsel G; Cüre MC; Beyazal M; Sahin I
    Clin Rheumatol; 2016 Sep; 35(9):2235-41. PubMed ID: 26847856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epicardial adipose tissue thickness in patients with ankylosing spondylitis.
    Resorlu H; Akbal A; Resorlu M; Gokmen F; Ates C; Uysal F; Adam G; Aylanc N; Arslan M; İnceer BS
    Clin Rheumatol; 2015 Feb; 34(2):295-9. PubMed ID: 24647981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of serum visfatin levels with clinical parameters, flow-mediated dilation, and carotid intima-media thickness in patients with ankylosing spondylitis.
    Aydoğan Baykara R; Küçük A; Tuzcu A; Tuzcu G; Cüre E; Uslu AU; Omma A
    Turk J Med Sci; 2021 Aug; 51(4):1865-1874. PubMed ID: 33754654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of subclinical atherosclerosis in ankylosing spondylitis: correlations with disease activity indices.
    Perrotta FM; Scarno A; Carboni A; Bernardo V; Montepaone M; Lubrano E; Spadaro A
    Reumatismo; 2013 Jul; 65(3):105-12. PubMed ID: 23884025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between serum 25-hydroxyvitamin D level and subclinical atherosclerosis in healthy population.
    Mohammadzadeh V; Mehrpour M; Ghoreishi A; Kamali K; Zamani B
    Curr J Neurol; 2020 Apr; 19(2):53-58. PubMed ID: 38011463
    [No Abstract]   [Full Text] [Related]  

  • 13. Syndecan 1 may slow the progression of subclinical atherosclerosis in patients with ankylosing spondylitis.
    Yilmaz PD; Kadiyoran C; Goktepe MH; Akkubak Y; Icli A; Kucuk A
    Clin Exp Hypertens; 2023 Dec; 45(1):2156529. PubMed ID: 36524421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urolithiasis in ankylosing spondylitis: Correlation with Bath ankylosing spondylitis disease activity index (BASDAI), Bath ankylosing spondylitis functional index (BASFI) and Bath ankylosing spondylitis metrology index (BASMI).
    Fallahi S; Jamshidi AR; Gharibdoost F; Mahmoud MI; Paragomi P; Nicknam MH; Farhadi E; Qorbani M
    Caspian J Intern Med; 2012; 3(4):508-13. PubMed ID: 24009925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relation between osteoporosis and vitamin D levels and disease activity in ankylosing spondylitis.
    Mermerci Başkan B; Pekin Doğan Y; Sivas F; Bodur H; Ozoran K
    Rheumatol Int; 2010 Jan; 30(3):375-81. PubMed ID: 19685057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reference centile charts for measures of disease activity, functional impairment, and metrology in ankylosing spondylitis.
    Taylor AL; Balakrishnan C; Calin A
    Arthritis Rheum; 1998 Jun; 41(6):1119-25. PubMed ID: 9627023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between serum vitamin D levels and intima-media thickness in term infants.
    Arman D; Çetiner Z
    Eur J Pediatr; 2019 Jul; 178(7):1087-1093. PubMed ID: 31119436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid intima-media thickness: an index for subclinical atherosclerosis in type 1 diabetes.
    Abdelghaffar S; El Amir M; El Hadidi A; El Mougi F
    J Trop Pediatr; 2006 Feb; 52(1):39-45. PubMed ID: 16000343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of subclinical atherosclerosis using ultrasound radiofrequency data technology in patients diagnosed with ankylosing spondylitis.
    Kaplanoglu H; Özişler C
    J Ultrasound Med; 2019 Mar; 38(3):703-711. PubMed ID: 30182506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinimetric evaluation of the bath ankylosing spondylitis metrology index in a controlled trial of pamidronate therapy.
    Jauregui E; Conner-Spady B; Russell AS; Maksymowych WP
    J Rheumatol; 2004 Dec; 31(12):2422-8. PubMed ID: 15570645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.